Asakura T, Aoki K, Tadokoro M, Nakagawa T, Furuta S
Department of Surgery, Cardiovascular Institute, Tokyo, Japan.
Nihon Kyobu Geka Gakkai Zasshi. 1997 Sep;45(9):1539-46.
The purpose of this study was to retrospectively evaluate the outcome of refractory infected mediastinitis managed primarily with mobilization of pectoral muscle flaps and omental transposition. From January 1992 to December 1995, infected mediastinitis occurred in 11 (2.5%) of 447 consecutive patients. All patients required sternal debridement. The wound was thoroughly irrigated with a solution of 0.5% povidone-iodine in physiological saline after debridement and then the defect was repaired. Reconstruction of the chest wall was attained using pectoral muscle flaps in seven patients and pectoral muscle flaps and omental transposition in four. Antibiotic therapy was provided for 6 weeks or more according to the regimen in North America. No hospital deaths occurred after surgery. Significant early complications occurred in four patients. The reasons for the prolonged hospitalization were a recurrent wound infection, prosthetic valve endocarditis and saphenous vein graft pseudoaneurysm formation caused by Methicillin-resistant Staphylococcus aureus (MRSA) and Methicillin-resistant Staphylococcus epidermidis (MRSE). Length of stay in ICU after surgical treatment was range 1 to 140 days (an average of 11 +/- 3 days in 9 patients without complications in ICU). Duration between surgical treatment and discharge was range 47 to 300 days (an average of 58 +/- 8 days in 7 patients without significant early complications). At the time of this report, the patients are doing well with no signs of recurrence of infection. The mean follow-up was 28.8 months (range 8 to 48 months). We conclude that single-stage mobilization of pectoral muscle flaps together with omental transposition is very usefull for managing refractory infected mediastinitis. But careful follow-up is needed after this procedure in case of MRSA-caused mediastinitis because of its tendency to recur.
本研究的目的是回顾性评估主要采用胸肌瓣转移和大网膜移位治疗难治性感染性纵隔炎的疗效。1992年1月至1995年12月,447例连续患者中有11例(2.5%)发生感染性纵隔炎。所有患者均需行胸骨清创术。清创后用0.5%聚维酮碘生理盐水溶液彻底冲洗伤口,然后修复缺损。7例患者采用胸肌瓣重建胸壁,4例采用胸肌瓣和大网膜移位。根据北美的治疗方案给予抗生素治疗6周或更长时间。术后无医院死亡病例。4例患者发生严重早期并发症。住院时间延长的原因是耐甲氧西林金黄色葡萄球菌(MRSA)和耐甲氧西林表皮葡萄球菌(MRSE)引起的伤口反复感染、人工瓣膜心内膜炎和大隐静脉移植假性动脉瘤形成。手术治疗后在重症监护病房(ICU)的住院时间为1至140天(9例无并发症的ICU患者平均为11±3天)。手术治疗至出院的时间为47至300天(7例无严重早期并发症的患者平均为58±8天)。在本报告时,患者情况良好,无感染复发迹象。平均随访28.8个月(范围8至48个月)。我们得出结论,胸肌瓣一期转移联合大网膜移位对于治疗难治性感染性纵隔炎非常有用。但由于MRSA引起的纵隔炎有复发倾向,术后需要仔细随访。